Greece
Qualitis SA is a Full-Service Clinical Research & Medical Consulting CRO, recently acquired by Optimapharm Group. It offers a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries. With a focus on superior quality service, integrity, and innovation, Qualitis aims to exceed its customers' needs and expectations, driven by a strong commitment to constant learning and improvement.
The company's team has extensive experience and expertise in clinical research and medical marketing, building upon the foundations of Quality, Commitment and Customer Trust. Their specialty areas include cardiovascular diseases, neurology & psychiatry, oncology, and various others, operating in projects such as Phase II-IV Clinical Trials, Medical Device Studies, and Epidemiological Studies.
Qualitis serves a diverse customer base, including pharmaceutical and biotechnology companies, medical device companies, as well as academic research institutes and hospitals. Founded in 2006, the company is headquartered in Greece.
Contact Details: E-mail: [email protected], Telephone: +30 210-7797750, Fax: +30 210-7470441.
Overall, Qualitis SA, now part of Optimapharm Group, stands as a promising player in the Health Care industry, driven by its strong commitment to quality, innovation, and customer satisfaction.
